Apple has a contingency plan to sell versions of the Apple Watch Series 9 and Ultra 2 without its Blood Oxygen monitoring feature depending on the outcome of an appeal in its case against Masimo and the International Trade Commission this week but is still selling both with the contested technology meantime.
Apple confirmed to iMore this week that both the Apple Watch Series 9 and the Apple Watch Ultra 2 remain on sale with Blood Oxygen monitoring intact, as the company awaits the outcome of its appeal against an order from the International Trade Commission banning the sale and import of both models in the United States.
